Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
Conditions
- Coronary Artery Disease
- Acute Coronary Syndrome
Interventions
- DRUG: Cangrelor
- DRUG: Prasugrel
Sponsor
University of Florida
Collaborators